Effect of cyclosporine on rubella virus-specific immune responses in chronic progressive multiple sclerosis

This publication has 27 references indexed in Scilit:

• Serial immune evaluation of cyclosporine- and placebo-treated multiple sclerosis patients
  Journal of Neuroimmunology, 1988
• Preliminary Results of a Double-Blind, Randomized, Placebo-Controlled Trial of Cyclosporine in Myasthenia Gravis
  New England Journal of Medicine, 1987
• Improved Chromatography of Cyclosporine
  Therapeutic Drug Monitoring, 1986
• Cyclosporin A inhibits antigen‐ and lectin‐induced but not constitutive production of interleukin 3
  European Journal of Immunology, 1985
• Cyclosporine inhibits prolactin induction of ornithine decarboxylase in rat tissues
  Molecular and Cellular Endocrinology, 1984
• Rating neurologic impairment in multiple sclerosis
  Neurology, 1983
• Gamma Interferon Synthesis by Human Thymocytes and T Lymphocytes Inhibited by Cyclosporin A
  Science, 1983
• Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2
  European Journal of Immunology, 1981
• LYMPHOCYTE TRANSFORMATION IN VITRO TO PARAMYXOVIRUS ANTIGENS IN MULTIPLE SCLEROSIS
  The Lancet, 1975
• PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS
  Annals of the New York Academy of Sciences, 1965